Pharmacogenomics Reporter GenomeWeb News Premium Content Existing subscribers login here. New to Pharmacogenomics Reporter? For a trial subscription click here.

With a 90-Percent Jump in Q2 Revenue,
Genomic Health Raises 2008 Guidance

[August 6, 2008]

By Turna Ray

In reporting a nearly 90-percent jump in revenues for the three months ended June 30, Genomic Health increased its yearly guidance this week, based on the reimbursement success and increasing adoption of its flagship product Oncotype DX.

Login | Subscribe